Last updated : May 22, 2026 11:40 am
Organizations that embrace it thoughtfully today will help shape a healthier tomorrow, for India and beyond
Artificial intelligence already transforms healthcare in powerful ways. It is enhancing skills of medical professionals, enhancing diagnosis, and opening the door to more individualized treatment plans. Multimodal AI takes this impact further. Instead of analysing one type of data at a time, it brings together clinical notes, lab reports, medical images, wearable signals, genomics, and patient history.
This creates a fuller, more accurate picture of a person’s health. Many of today’s care gaps stem from fragmented information, delayed action, and decisions based on incomplete data. Multimodal AI helps address these gaps. Healthcare has long relied on isolated systems and disconnected records. Data silos, uneven standards, privacy concerns, and the lack of one clean-shared clinical record across settings create challenges. Multimodal AI converts scattered data into practical clinical intelligence.
Converging Data Silos into Clinical Intelligence
The biggest promises of multimodal AI is the possibility of connecting data silos that usually sit apart in practice. Patients imaging results, medication history, wearable signals, electronic health records, and claims data may each tell part of the story, but the real insight appears when they are analysed together. Research on multimodal AI in medicine shows that combining modalities can improve diagnostic accuracy and prognostic prediction compared with unimodal models.
This is especially important in healthcare systems where central repositories are still evolving in India and many other markets: healthcare data is often spread across hospitals, labs, private providers, and digital tools, making integration difficult. Multimodal AI does not solve infrastructure problems on its own, but it can make existing data more useful once it is harmonised and made interoperable.
In India, the Ayushman Bharat Digital Mission (ABDM) and its Ayushman Bharat Health Account (ABHA) framework are beginning to create the interoperable backbone that multimodal AI needs. Public and private systems still sit apart in many places, but progress on Health IDs and standardised exchange is accelerating.
Reactive Care to Proactive Risk Stratification
Healthcare often becomes active only after symptoms become severe. Multimodal AI offers a shift from reactive treatment to proactive risk stratification, which means identifying risk earlier and acting before the condition escalates. With multimodal AI, health systems combine claims data, EHR/EMR records, personal health records, and wellness signals from wearables. They build risk profiles, identify cohorts (such as groups of patients at high risk for diabetes), and further stratify them by severity level.
This is where AI can add real value. By combining clinical records with behavioural and physiological data, health systems can segment patients into risk cohorts and design targeted care plans. This approach is already being explored in population health management, where the goal is not only to treat disease, but also to reduce avoidable hospital visits, emergency admissions, and long-term complications.
Enhancing Diagnostic Accuracy and Reducing Human Bias
Clinical diagnosis is complex. Even skilled professionals can miss patterns when data feels incomplete or overwhelming. Multimodal AI strengthens accuracy by comparing signals across different data types and surfacing connections that a single test might hide.
Studies in oncology, ophthalmology, and radiology show that multimodal approaches deliver gains—often 2–7% higher accuracy and 4–5% AUC improvement over single-modality systems. These models also help reduce certain forms of human bias by anchoring decisions in a broader evidence base rather than one isolated observation.
Importantly, multimodal AI does not replace clinicians. It adds a more complete decision-making layer. Success depends on high-quality training data, strong explainability, and ongoing clinical validation—so the technology supports human judgment instead of obscuring it.
Real-Time Clinical Decision Support
Speed matters in healthcare. When a patient’s condition can change quickly, Multimodal AI can support real-time clinical decision-making by continuously processing new inputs such as vitals, imaging updates, lab results, and monitoring data. This can help care teams detect deterioration earlier, prioritise urgent cases, and adjust treatment plans faster.
Care teams can detect deterioration earlier, prioritise urgent cases, and adjust treatment plans faster. If wearable signals, symptoms, and recent tests all point toward rising risk, the system flags the pattern before the situation turns critical. This capability improves triage, smooths care coordination, and enables more timely intervention in fast-moving clinical environments.
Ethical AI, Data Privacy, and Regulatory Readiness
As healthcare becomes more data-driven, the responsibility to protect patient information becomes even more important. Privacy, consent, regulatory standards, and secure data exchange sit at the heart of any responsible deployment. Multimodal AI works only when people trust the system—and trust rests on transparency, consent, and strong governance.
Cybersecurity is no longer a side issue. Healthcare continues to face persistent breach and ransomware risk, and public reports show that the sector remains a major target for cyberattacks. For AI-enabled healthcare tools, security must cover the full lifecycle: data collection, storage, model training, deployment, and post-market monitoring. The FDA’s 2025 draft guidance also reflects this direction by stressing cybersecurity risk management for AI-enabled device software functions.
In India, the Digital Personal Data Protection (DPDP) Act 2023, combined with ABDM’s consent and anonymisation protocols, sets clear guardrails for responsible data exchange. Healthcare organisations must treat privacy-by-design, explainable AI, bias monitoring, and cybersecurity as non-negotiable from day one. The future of multimodal AI will not be judged only by how smart it is, but by how safe, fair, and accountable it is.
Multimodal AI is not a distant promise, but represents the practical next step toward proactive, personalised, and privacy-first healthcare. Organisations that embrace it thoughtfully today will help shape a healthier tomorrow—for India and beyond.
About Author: Ashwattha Sahasrabuddhe is the Principal Architect and Technology & Practice Head – Healthcare Business at Tata Elxsi. He is a technology and engineering leader with extensive experience in digital transformation, healthcare technology, and enterprise innovation. Over the course of his career, he has led strategic initiatives across healthcare, pharma, and intelligent industry domains.